These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27462831)

  • 1. LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition.
    Márquez A; Fernández-Aranguren T; Witte T; González-Gay MA; Martín J; ;
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):208-209. PubMed ID: 27462831
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of IL2RA rs2104286 polymorphism in the risk of biopsy-proven giant cell arteritis.
    Rodríguez-Rodríguez L; Castañeda S; Vázquez-Rodríguez TR; Morado IC; Marí-Alfonso B; Gómez-Vaquero C; Miranda-Filloy JA; Ortego-Centeno N; Narvaez J; Blanco R; Fernández-Gutiérrez B; Martín J; González-Gay MA
    J Rheumatol; 2010 Nov; 37(11):2331-3. PubMed ID: 20810507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis.
    Rodríguez-Rodríguez L; Castañeda S; Vázquez-Rodríguez TR; Morado IC; Gómez-Vaquero C; Marí-Alfonso B; Miranda-Filloy JA; Narvaez J; Ortego-Centeno N; Vicente EF; Blanco R; Amigo-Diaz E; Fernández-Gutiérrez B; Martin J; González-Gay MA
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S12-6. PubMed ID: 21269573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility.
    González-Serna D; Carmona EG; Ortego-Centeno N; Simeón CP; Solans R; Hernández-Rodríguez J; Tolosa C; Castañeda S; Narváez J; Martinez-Valle F; ; ; Witte T; Neumann T; Holle J; Beretta L; Boiardi L; Emmi G; Cimmino MA; Vaglio A; Herrick AL; Denton CP; Salvarani C; Cid MC; Morgan AW; Fonseca C; González-Gay MA; Martín J; Márquez A
    PLoS One; 2018; 13(12):e0209343. PubMed ID: 30586461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis.
    Serrano A; Carmona FD; Castañeda S; Miranda-Filloy JA; Morado IC; Gomez-Vaquero C; Solans R; Sopeña B; Blanco R; Unzurrunzaga A; Ortego-Centeno N; Marí-Alfonso B; Hidalgo-Conde A; Hernández-Rodríguez J; Cid MC; Martín J; Gonzalez-Gay MA
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S5-8. PubMed ID: 23306142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of rs1343151 IL23R and rs3790567 IL12RB2 polymorphisms in biopsy-proven giant cell arteritis.
    Rodríguez-Rodríguez L; Carmona FD; Castañeda S; Miranda-Filloy JA; Morado IC; Narváez J; Marí-Alfonso B; Gómez-Vaquero C; Amigo-Díaz E; Ríos-Fernández R; Blanco R; Llorca J; Fernández-Gutiérrez B; Martín J; González-Gay MA
    J Rheumatol; 2011 May; 38(5):889-92. PubMed ID: 21285166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune disease-associated CD226 gene variants are not involved in giant cell arteritis susceptibility in the Spanish population.
    Serrano A; Carmona FD; Miranda-Filloy JA; Castañeda S; Rodríguez-Rodríguez L; Morado IC; Gómez-Vaquero C; Solans R; Sopeña B; Blanco R; Unzurrunzaga A; Ortego-Centeno N; Marí-Alfonso B; de Miguel E; Hidalgo-Conde A; Martín J; González-Gay MA
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S29-33. PubMed ID: 22512842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the CCR5/Δ32CCR5 polymorphism in biopsy-proven giant cell arteritis.
    Carmona FD; Rodríguez-Rodríguez L; Castañeda S; Miranda-Filloy JA; Morado IC; Narváez J; Marí-Alfonso B; Unzurrunzaga A; Ríos-Fernández R; Blanco R; de Miguel E; Martín J; González-Gay MA
    Hum Immunol; 2011 May; 72(5):458-61. PubMed ID: 21354457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epistatic interactions between HLA-DRB1 and interleukin 4, but not interferon-gamma, increase susceptibility to giant cell arteritis.
    Amoli MM; Gonzalez-Gay MA; Zeggini E; Salway F; Garcia-Porrua C; Ollier WE
    J Rheumatol; 2004 Dec; 31(12):2413-7. PubMed ID: 15570643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LILRA3 deletion is a genetic risk factor of HIV infection.
    Ahrenstorf G; Low HZ; Kniesch K; Ordonez D; Meyer-Olson D; Ahmad F; Kücherer C; Gunsenheimer-Bartmeyer B; Stoll M; Matthias T; Schmidt RE; Witte T
    AIDS; 2017 Jan; 31(1):25-34. PubMed ID: 27755104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis.
    Rueda B; Lopez-Nevot MA; Lopez-Diaz MJ; Garcia-Porrua C; Martín J; Gonzalez-Gay MA
    J Rheumatol; 2005 Sep; 32(9):1737-41. PubMed ID: 16142870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein gene polymorphisms in biopsy-proven giant cell arteritis from Northwestern Spain.
    Palomino-Morales R; Vazquez-Rodriguez TR; Miranda-Filloy JA; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2009 Feb; 36(2):341-6. PubMed ID: 19040303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain.
    Martin J; Perez-Armengol C; Miranda-Filloy JA; Vilchez JR; Lopez-Nevot MA; Garcia-Porrua C; Gonzalez-Gay MA
    J Rheumatol; 2006 Feb; 33(2):285-8. PubMed ID: 16465659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis.
    Palomino-Morales R; Torres O; Vazquez-Rodriguez TR; Morado IC; Castañeda S; Callejas-Rubio JL; Miranda-Filloy JA; Fernandez-Gutierrez B; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2009 Jul; 36(7):1501-6. PubMed ID: 19531762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of CD24 gene polymorphisms with susceptibility to biopsy-proven giant cell arteritis.
    Rueda B; Miranda-Filloy JA; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2008 May; 35(5):850-4. PubMed ID: 18381780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between IRF5 gene polymorphisms and biopsy-proven giant cell arteritis.
    Torres O; Palomino-Morales R; Vazquez-Rodriguez TR; Castañeda S; Morado IC; Miranda-Filloy JA; Valero F; Callejas-Rubio JL; Fernandez-Gutierrez B; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2010 Jan; 37(1):136-40. PubMed ID: 19918036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis.
    Carmona FD; Serrano A; Rodríguez-Rodríguez L; Callejas JL; Simeón CP; Carreira P; Castañeda S; Solans R; Blanco R; ; ; González-Gay MA; Martín J
    J Rheumatol; 2012 Jun; 39(6):1275-9. PubMed ID: 22589256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis.
    Amoli MM; Garcia-Porrua C; Ollier WE; Gonzalez-Gay MA
    J Rheumatol; 2005 Jan; 32(1):74-6. PubMed ID: 15630728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonsynonymous functional variant of the ITGAM gene is not involved in biopsy-proven giant cell arteritis.
    Carmona FD; Serrano A; Rodríguez-Rodríguez L; Castañeda S; Miranda-Filloy JA; Morado IC; Narváez J; Solans R; Sopeña B; Marí-Alfonso B; Unzurrunzaga A; Ortego-Centeno N; Blanco R; de Miguel E; Hidalgo-Conde A; Martín J; González-Gay MA
    J Rheumatol; 2011 Dec; 38(12):2598-601. PubMed ID: 21965647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial nitric oxide synthase haplotype associations in biopsy-proven giant cell arteritis.
    Amoli MM; Garcia-Porrua C; Llorca J; Ollier WE; Gonzalez-Gay MA
    J Rheumatol; 2003 Sep; 30(9):2019-22. PubMed ID: 12966609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.